AIRS
Airsculpt Technologies Inc
NASDAQ: AIRS · HEALTHCARE · MEDICAL CARE FACILITIES
$2.54
+2.83% today
Updated 2026-04-29
Market cap
$174.25M
P/E ratio
—
P/S ratio
1.18x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $12
Volume
3.0M
Airsculpt Technologies Inc (AIRS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $41.24M | $62.77M | $133.31M | $168.79M | $195.92M | $180.35M | $151.82M |
| Revenue growth (YoY) | — | +52.2% | +112.4% | +26.6% | +16.1% | -7.9% | -15.8% |
| Cost of revenue | $15.49M | $23.47M | $44.54M | $58.28M | $74.01M | $71.38M | $61.69M |
| Gross profit | $25.75M | $39.30M | $88.78M | $110.51M | $121.91M | $108.97M | $90.13M |
| Gross margin | 62.4% | 62.6% | 66.6% | 65.5% | 62.2% | 60.4% | 59.4% |
| R&D | — | — | — | — | — | — | — |
| SG&A | $12.93M | $16.62M | $50.93M | $85.32M | $82.38M | $72.18M | $82.18M |
| Operating income | $663000.00 | $10.03M | $15.77M | $-4.54M | $9.48M | $-1.82M | $-4.83M |
| Operating margin | 1.6% | 16.0% | 11.8% | -2.7% | 4.8% | -1.0% | -3.2% |
| EBITDA | $5.62M | $15.67M | $22.36M | $4.59M | $19.74M | $10.07M | $1.22M |
| EBITDA margin | 13.6% | 25.0% | 16.8% | 2.7% | 10.1% | 5.6% | 0.8% |
| EBIT | $663000.00 | $10.03M | $15.77M | $-3.47M | $9.48M | $-1.82M | $-11.56M |
| Interest expense | $2.88M | $2.46M | $4.89M | $6.75M | $6.49M | $6.25M | $6.08M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.21M | $7.58M | $10.55M | $-14.68M | $-4.48M | $-8.25M | $-11.67M |
| Net income growth (YoY) | — | +442.5% | +39.3% | -239.1% | +69.5% | -84.2% | -41.4% |
| Profit margin | -5.4% | 12.1% | 7.9% | -8.7% | -2.3% | -4.6% | -7.7% |